ALK and neoplasm: Using RT-PCR and deep amplicon sequencing, Best et al. [9] also detected tumor-derived RNA, including translocated EML4-ALK transcripts as well as KRAS and EGFR transcripts harboring tumor-specific point mutations, in platelets from NSCLC patients.